Esaote, a leading global medical imaging company, announced a strategic partnership with Schiller Americas, a top provider of cardiopulmonary diagnostics, to expand their presence in the U.S. cardiovascular imaging market. This collaboration aims to bring Esaote’s advanced ultrasound technology to a wider range of healthcare providers across the country. Under the agreement, Schiller Americas will distribute Esaote’s ultrasound systems, including the MyLab E80, MyLab A70, and MyLab Omega eXP, to its extensive network of cardiology professionals. Together, the companies will provide comprehensive diagnostic solutions designed to improve cardiac care and patient outcomes.
Health Technology Insights: Freenome Names Rob Guigley CCO as Exact Sciences Deal Clears
Thomas Will, Director of Ultrasound Sales at Esaote North America, said that Esaote and Schiller have had a strong global relationship for many years and this partnership extends that collaboration into the U.S. market. He emphasized that the two companies’ technologies complement each other, combining Schiller’s expertise in cardiopulmonary diagnostics with Esaote’s leadership in ultrasound imaging to equip clinicians with a complete diagnostic toolkit.
Health Technology Insights: Headspace and Cigna Launch Enhanced Mental Health Support
Francesco Iacona, CEO of Schiller Americas, added that the partnership sets a new benchmark for diagnostic accuracy in cardiopulmonary care in the United States. He highlighted that combining Esaote’s ultrasound proficiency with Schiller’s diagnostic capabilities creates a powerful offering for clinicians, enhancing both precision and workflow efficiency.
The collaboration reinforces the commitment of both organizations to advancing cardiovascular imaging and supporting physicians with flexible, high-quality solutions that improve patient outcomes. By uniting their strengths, Esaote and Schiller aim to deliver innovative diagnostic tools that streamline clinical processes while providing detailed insights for more accurate patient care.
This partnership represents a key milestone for both companies as they work together to strengthen their U.S. presence, enhance the standard of cardiovascular diagnostics, and ensure clinicians have access to cutting-edge imaging technology that supports better treatment decisions and patient care nationwide.
Health Technology Insights: AI, Quantum and Biotech Drive Trillion-Dollar Health Shift at GITEX
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
